Dr.Surbhi Kansal and Mainsha Jain 2026. IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE. Journal of Population Therapeutics and Clinical Pharmacology. 33, 2 (May 2026), 841–852. DOI:https://doi.org/10.69980/1gsrfr34.